Casdin Capital »

Singular Genomics Systems In shares owned by Casdin Capital

Quarter-by-quarter ownership of Singular Genomics Systems In (OMIC) shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in Singular Genomics Systems In

Tip: Access up to 7 years of quarterly data

All positions including Singular Genomics Systems In held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Singular Genomics Systems In by Casdin Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $373k 44k 8.45

More positions owned by Casdin Capital

Biolife Solutions Com New (BLFS)
Revolution Medicines (RVMD)
Genedx Holdings Corp Com Cl A (WGS)
D Fluidigm Corp Del (LAB)
Sarepta Therapeutics (SRPT)
Illumina (ILMN)
Avidity Biosciences Ord (RNA)
Relay Therapeutics (RLAY)
Alnylam Pharmaceuticals (ALNY)
EXACT Sciences Corporation (EXAS)
Intellia Therapeutics (NTLA)
Structure Therapeutics Sponsored Ads (GPCR)
Blueprint Medicines (BPMC)
Denali Therapeutics (DNLI)
Codexis (CDXS)

View all positions for Casdin Capital

Top funds holding Singular Genomics Systems In

Tang Capital Management
Deerfield Management Company
Arch Venture Corp
QVIDTVM Management
Vanguard Group
Perceptive Advisors
BlackRock
Geode Capital Management
HighTower Advisors
BlackRock
Tikvah Management
Tower Research Capital
Barclays
Bank of America Corporation
Morgan Stanley

View all funds holding Singular Genomics Systems In